134 related articles for article (PubMed ID: 12684650)
1. Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma.
Todaro LB; Ladeda V; Bal de Kier Joffé E; Farías EF
Oncol Rep; 2003; 10(3):725-32. PubMed ID: 12684650
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
[TBL] [Abstract][Full Text] [Related]
3. Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model.
Alonso DF; Farías EF; Ladeda V; Davel L; Puricelli L; Bal de Kier Joffé E
Breast Cancer Res Treat; 1996; 40(3):209-23. PubMed ID: 8883963
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T
Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
[TBL] [Abstract][Full Text] [Related]
5. Autocrine and paracrine regulation of tissue inhibitor of metalloproteinases, transin, and urokinase gene expression in metastatic and nonmetastatic mammary carcinoma cells.
Korczak B; Kerbel RS; Dennis JW
Cell Growth Differ; 1991 Jul; 2(7):335-41. PubMed ID: 1782152
[TBL] [Abstract][Full Text] [Related]
6. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes.
Yu HR; Schultz RM
Cancer Res; 1990 Dec; 50(23):7623-33. PubMed ID: 1701350
[TBL] [Abstract][Full Text] [Related]
7. The antibody to plasminogen activator inhibitor-1 suppresses pulmonary metastases of human fibrosarcoma in athymic mice.
Tsuchiya H; Katsuo S; Matsuda E; Sunayama C; Tomita K; Ueda Y; Binder BR
Gen Diagn Pathol; 1995 May; 141(1):41-8. PubMed ID: 8542506
[TBL] [Abstract][Full Text] [Related]
8. Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma.
Alonso DF; Farías EF; Urtreger A; Ladeda V; Vidal MC; Bal De Kier Joffé E
J Surg Oncol; 1996 Aug; 62(4):288-97. PubMed ID: 8691844
[TBL] [Abstract][Full Text] [Related]
9. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells.
Hearing VJ; Law LW; Corti A; Appella E; Blasi F
Cancer Res; 1988 Mar; 48(5):1270-8. PubMed ID: 2963689
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse.
Ossowski L; Russo-Payne H; Wilson EL
Cancer Res; 1991 Jan; 51(1):274-81. PubMed ID: 1988089
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action.
Inokuchi J; Jimbo M; Momosaki K; Shimeno H; Nagamatsu A; Radin NS
Cancer Res; 1990 Oct; 50(20):6731-7. PubMed ID: 2145065
[TBL] [Abstract][Full Text] [Related]
12. Suppression of metastatic potential of high-metastatic Lewis lung carcinoma cells by vanadate, an inhibitor of tyrosine phosphatase, through inhibiting cell-substrate adhesion.
Takenaga K
Invasion Metastasis; 1996; 16(2):97-106. PubMed ID: 9030244
[TBL] [Abstract][Full Text] [Related]
13. Tumor invasion-inhibiting factor 2: primary structure and inhibitory effect on invasion in vitro and pulmonary metastasis of tumor cells.
Isoai A; Giga-Hama Y; Shinkai K; Mukai M; Akedo H; Kumagai H
Cancer Res; 1992 Mar; 52(6):1422-6. PubMed ID: 1311631
[TBL] [Abstract][Full Text] [Related]
14. The effect of thrombospondin on invasion of fibrin gels by human A549 lung carcinoma.
Hosokawa T; Muraishi A; Rothman VL; Papale M; Tuszynski GP
Oncol Res; 1993; 5(4-5):183-9. PubMed ID: 8305744
[TBL] [Abstract][Full Text] [Related]
15. Verapamil inhibits to different extents agonist-induced Ca2+ transients in human tumor cells and in vitro tumor cell growth.
Brocchieri A; Saporiti A; Moroni M; Porta C; Tua A; Grignani G
Invasion Metastasis; 1996; 16(2):56-64. PubMed ID: 9030240
[TBL] [Abstract][Full Text] [Related]
16. Suppression of pulmonary metastases of rat mammary cancer by recombinant urokinase plasminogen activator inhibitor.
Evans DM; Lin PL
Am Surg; 1995 Aug; 61(8):692-6; discussion 696-7. PubMed ID: 7618808
[TBL] [Abstract][Full Text] [Related]
17. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
Eccles SA; Box GM; Court WJ; Bone EA; Thomas W; Brown PD
Cancer Res; 1996 Jun; 56(12):2815-22. PubMed ID: 8665519
[TBL] [Abstract][Full Text] [Related]
18. Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA).
Rabbani SA; Harakidas P; Davidson DJ; Henkin J; Mazar AP
Int J Cancer; 1995 Dec; 63(6):840-5. PubMed ID: 8847143
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.
Watson SA; Morris TM; Robinson G; Crimmin MJ; Brown PD; Hardcastle JD
Cancer Res; 1995 Aug; 55(16):3629-33. PubMed ID: 7627972
[TBL] [Abstract][Full Text] [Related]
20. Coordinate inhibition of plasminogen activator and tumor growth by hydrocortisone in mouse mammary carcinoma.
Mira-y-Lopez R; Reich E; Stolfi RL; Martin DS; Ossowski L
Cancer Res; 1985 May; 45(5):2270-6. PubMed ID: 2985248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]